Spectrum Group International Announces Proposed Cash Election Merger
April 18, 2024 16:05 ET
|
Spectrum Group International, Inc.
COSTA MESA, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Spectrum Group International, Inc. (SPGZ) (“SGI” or the “Company”), an integrated network of leading companies concentrating on numismatics...
Westland Insurance releases ultimate guide to home insurance in Canada
February 08, 2024 13:48 ET
|
Westland Insurance Group Ltd.
Surrey, BC/Territories of the Coast Salish (Kwantlen, Katzie, Semiahmoo, Tsawwassen First Nations), Feb. 08, 2024 (GLOBE NEWSWIRE) -- Westland Insurance (Westland), Canada's fastest growing...
Serstech receives order of 10,5 MSEK from Singapore
January 29, 2024 02:45 ET
|
Serstech
Serstech today received an order of 10,5 MSEK from its partner Kaiser-SGI in Singapore. The order contains Serstech Arx, the patented SERS kit and Serstech ChemDash software. The order will be...
BioSenic signe un nouvel accord de souscription pour un maximum de 1,2 M€ en obligations convertibles
January 08, 2024 12:00 ET
|
BioSenic
BioSenic signe un nouvel accord de souscription pour un maximum de 1,2 M€ en obligations convertibles Mont-Saint-Guibert, Belgique, le 8 décembre 2024 à 18h00 CEST – BIOSENIC Euronext Bruxelles et...
Correction : BioSenic progresse pour trouver les fonds nécessaires à la réalisation de son essai clinique clé sur la maladie chronique du greffon contre l'hôte
December 08, 2023 01:00 ET
|
BioSenic
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIÉE Ceci est une version corrigée du communiqué de presse original " BioSenic progresse pour trouver les fonds nécessaires à la réalisation de son...
ERRATUM: BioSenic on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host Disease
December 08, 2023 01:00 ET
|
BioSenic
PRESS RELEASE – INSIDE INFORMATION This is a corrected version of the original PR " BioSenic on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host...
BioSenic progresse pour trouver les fonds nécessaires à la réalisation de son essai clinique clé sur la maladie chronique du greffon contre l'hôte
December 06, 2023 01:00 ET
|
BioSenic
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIÉE Biosenic signe un protocole d’accord avec SPRIM Global Investments (fonds TrialCap) pour un financement par emprunt de 8 millions d'USD et une...
BioSenic on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host Disease
December 06, 2023 01:00 ET
|
BioSenic
PRESS RELEASE – INSIDE INFORMATION Biosenic signs term sheet with SPRIM Global Investments (TrialCap fund) for up to USD 8 million debt financing and USD 800,000 equity investment...
LTE, VoLTE, and IMS Network Automated Testing Solutions
October 04, 2023 11:59 ET
|
GL Communications, Inc.
GL’s LTE IMS solutions ensure seamless wireless performance. Emulate, monitor, and troubleshoot networks effectively.
Spexis provides business update and announces financial results for the first half of 2023
September 29, 2023 01:30 ET
|
Spexis AG
Spexis provides business update and announces financial results for the first half of 2023